Electromed (ELMD) EBITDA Margin (2010 - 2026)
Electromed (ELMD) reported EBITDA Margin of 20.27% for Q1 2026, up 663.0% year-over-year from 2.66% in Q1 2025, and up 5.84% on a QoQ basis from 19.16% in Q4 2025.
Electromed (ELMD) has 17 years of EBITDA Margin data on file, last reported at 20.27% in Q1 2026.
- Quarterly EBITDA Margin rose 663.0% year-over-year to 20.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.25% (up 1198.0% YoY) and the FY2025 annual result came in at 15.09%, up 1239.0% from the prior year.
- EBITDA Margin improved to 20.27% in Q1 2026 per ELMD's latest filing, from 19.16% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.27% in Q1 2026 and bottomed at 18.67% in Q2 2024.
- The 5-year median for EBITDA Margin is 13.21% (2024), against an average of 8.79%.
- The widest annual swing landed in 2023, when EBITDA Margin slumped 1656 bps; it then jumped 3615 bps in 2025.
- Tracing ELMD's EBITDA Margin over 5 years: stood at 10.86% in 2022, then jumped by 52 bps to 16.53% in 2023, then slipped by 5 bps to 15.64% in 2024, then rose by 22 bps to 19.16% in 2025, then climbed by 6 bps to 20.27% in 2026.
- Per Business Quant, the three latest ELMD EBITDA Margin figures stand at 20.27% (Q1 2026), 19.16% (Q4 2025), and 15.81% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn | 20.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.27% |
| Dec 31, 2025 | 19.16% |
| Sep 30, 2025 | 15.81% |
| Jun 30, 2025 | 17.48% |
| Mar 31, 2025 | 13.64% |
| Dec 31, 2024 | 15.64% |
| Sep 30, 2024 | 13.21% |
| Jun 30, 2024 | -18.67% |
| Mar 31, 2024 | 13.27% |
| Dec 31, 2023 | 16.53% |
| Sep 30, 2023 | 1.15% |
| Jun 30, 2023 | -12.17% |
| Mar 31, 2023 | 9.91% |
| Dec 31, 2022 | 10.86% |
| Sep 30, 2022 | 0.41% |
| Jun 30, 2022 | 4.39% |
| Mar 31, 2022 | 8.51% |
| Dec 31, 2021 | 10.50% |
| Sep 30, 2021 | 5.38% |
| Jun 30, 2021 | -19.25% |
| Mar 31, 2021 | 2.77% |
| Dec 31, 2020 | 16.67% |
| Sep 30, 2020 | 8.28% |
| Jun 30, 2020 | 18.75% |
| Mar 31, 2020 | 10.44% |
| Dec 31, 2019 | 18.33% |
| Sep 30, 2019 | 16.24% |
| Jun 30, 2019 | -8.49% |
| Mar 31, 2019 | 6.27% |
| Dec 31, 2018 | 8.42% |
| Sep 30, 2018 | 2.77% |
| Jun 30, 2018 | 16.06% |
| Mar 31, 2018 | 8.06% |
| Dec 31, 2017 | 11.07% |
| Sep 30, 2017 | 1.57% |
| Jun 30, 2017 | -11.80% |
| Mar 31, 2017 | 15.54% |
| Dec 31, 2016 | 11.45% |
| Sep 30, 2016 | 5.21% |
| Jun 30, 2016 | 9.47% |
| Mar 31, 2016 | 12.19% |
| Dec 31, 2015 | 19.95% |
| Sep 30, 2015 | 11.70% |
| Jun 30, 2015 | -9.37% |
| Mar 31, 2015 | 1.26% |
| Dec 31, 2014 | 9.16% |
| Sep 30, 2014 | 8.34% |
| Jun 30, 2014 | 17.87% |
| Mar 31, 2014 | -5.49% |
| Dec 31, 2013 | -8.82% |
| Sep 30, 2013 | -16.89% |
| Jun 30, 2013 | 18.03% |
| Mar 31, 2013 | -21.69% |
| Dec 31, 2012 | -15.44% |
| Sep 30, 2012 | -2.39% |
| Jun 30, 2012 | -3.76% |
| Mar 31, 2012 | 4.73% |
| Dec 31, 2011 | 2.09% |
| Sep 30, 2011 | 8.41% |
| Jun 30, 2011 | 8.23% |
| Mar 31, 2011 | 12.92% |
| Dec 31, 2010 | 11.59% |
| Sep 30, 2010 | 5.95% |